Clinical characteristics, epidemiology, and mortality of patients receiving antifungal therapy at a university hospital of the Triângulo Mineiro, Brazil

Authors

  • Reginaldo dos Santos Pedroso Universidade Federal de Uberlândia https://orcid.org/0000-0003-3010-5754
  • Flávia Maria Pinto Monteiro Antonieti
  • Maria Ângela Ribeiro
  • Lúcio Borges de Araújo
  • Denise Von Dolinger de Brito Roder

DOI:

https://doi.org/10.17058/reci.v14i1.18687

Abstract

Background and Objectives: Invasive fungal infections are associated with high morbidity and mortality in patients admitted to hospital, including those receiving appropriate therapy. The aim of this study was to evaluate the use of prophylactic and preemptive antifungal therapy; clinical and epidemiological features; and mortality of patients admitted to an infectious disease ward of a public high complexity hospital in Uberlandia, Minas Gerais, Brazil. Methods: This is a retrospective study carried out in the infectious diseases ward of a public university hospital in Brazil. Data from patients hospitalized in 2019 and 2020 who received azole antifungals (fluconazole, itraconazole, or voriconazole), echinocandin (anidulafungin), and polyene (amphotericin B) were collected from medical records. Results: During the study period, 111 patients received one or more antifungal agent. The length of hospital stays of patients (29.35 days; p=0.0252), mean number of days of antibacterial drug use (23.5 days; p=0.0164), a diagnosis of AIDS (p=0.0397), mechanical ventilation (MV) (p<0.001), and presence of a nasoenteral tube (p<0.01) were variables that were associated with death. Fungal infection was confirmed in 79 (71.2%) patients who used antifungal drugs. The most frequent fungi isolated were Candida spp. (36; 32.4%) and Cryptococcus spp. (22; 19.8%), and there was an association between infection with these fungi and mortality (p<0.05; OR: 7.61 and 5.53, respectively). Regarding antifungal therapy indication, 56 (50.4%) patients received it as empirical therapy, 33 (29.7%) as targeted therapy, and 22 (19.8%) as preemptive therapy. Conclusion: The factors that contributed to mortality of the patients were longer hospital stays, AIDS, antibacterial medication use, mechanical ventilation, and presence of a nasoenteral tube. The type of antifungal therapy used did not influence the mortality in these patients.

Downloads

Download data is not yet available.

References

Bongomin F, Gago S, Oladele RO, et al. Global and multi-national prevalence of fungal diseases- estimate precision. J Fungi (Basel). 2017;3(4):57. https://doi.org/10.3390/jof3040057

Van Rhijn N, Bromley M. The consequences of our changing environment on life threatening and debilitating fungal diseases in humans. J Fungi (Basel). 2021;7(5):367. https://doi.org/10.3390/jof7050367

Pemán J, Zaragoza R, Salavert M. Control y prevención de las infecciones nosocomiales y asociadas a cuidados sanitários causadas por especies de Candida y otras levaduras. Rev Esp Chemioter. 2013;26(4):298–311. https://seq.es/seq/0214-3429/26/4/peman.pdf

Jenks JD, Cornely OA, Chen SC, et al. Breakthrough invasive fungal infections: Who is at risk? Mycoses. 2020;63(10):1021–32. https://doi.org/10.1111/myc.13148

Vitális E, Nagy F, Tóth Z, et al. Candida biofilm production is associated with higher mortality in patients with candidaemia. Mycoses. 2020;63(4):352–60. https://doi.org/10.1111/myc.13049

González-Lara MF, Torres-González P, Rangel-Cordero A, et al. Identification and susceptibility testing of Candida spp. directly from yeast-positive blood cultures with Vitek 2. Diagn Microbiol Infect Dis. 2017;89(3):202–4. https://doi.org/10.1016/j.diagmicrobio.2017.07.004

Neufeld PM. COVID-19 and the diagnosis of invasive pulmonary aspergillosis. Revista Brasileira de Análises Clínicas. 2020;52(2):173–5. https://doi.org/10.21877/2448-3877.20200019

Mourad A, Perfect JR. Present and future therapy of Cryptococcus infections. J Fungi (Basel). 2018;4(3):79. https://doi.org/10.3390/jof4030079

Aguiar PADF, Pedroso RDS, Borges AS, et al. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital. Rev Inst Med Trop Sao Paulo. 2017;59:e13. https://doi.org/10.1590/S1678-9946201759013

Damasceno-Escoura AH, Mora DJ, Cardeal AC, et al. Histoplasmosis in HIV-infected patients: Epidemiological, clinical and necropsy data from a Brazilian teaching hospital. Mycopathologia. 2020;185(2):339–46. https://doi.org/10.1007/s11046-020-00435-y

Gavronski, S, Botelho, TKR., Cordova, CMM. Laboratory diagnosis of invasive aspergillosis: evaluation of molecular methods and antigen detection. Revista Brasileira de Análises Clínicas. 2016; 48(2): 96–109. https://www.rbac.org.br/artigos/diagnostico-laboratorial-de-aspergilose-invasiva-avaliacao-de-metodos-moleculares-e-deteccao-de-antigenos-48-n-2/

Cornely OA, Lass-Flörl C, Lagrou K, et al. Improving outcome of fungal diseases - Guiding experts and patients towards excellence. Mycoses 2017;60(7):420–5. https://doi.org/10.1111/myc.12628

Nivoix Y, Launoy A, Lutun P, et al. Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. J Antimicrob Chemother. 2012;67(10):2506–13. https://doi.org/10.1093/jac/dks256

Brasil. Gerência Geral de Tecnologia et al. Nota técnica GVIMS/GGTES/ANVISA nº 04/2021: orientações para vigilância, identificação, prevenção e controle de infecções fúngicas invasivas em serviços de saúde no contexto da pandemia da COVID-19. 2021. https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/notas-tecnicas/notas-tecnicas-vigentes/nota-tecnica-04-2021-infeccoes-fungicas-e-covid19.pdf/view. Accessed on February 2nd, 2024.

Colombo AL, Guimaraes T; Camargo LFA, et al. Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Braz J Infect Dis. 2013;7(3):283–312. http://dx.doi.org/10.1016/j.bjid.2013.02.001

Souza MC, Santos AG, Reis AM. Drug utilization study of systemic antifungal agents in a Brazilian tertiary care hospital. Int J Clin Pharm. 2016;38(6):1398–406. https://doi.org/10.1007/s11096-016-0382-6

Koch E, Rada G. Is preemptive antifungal therapy a good alternative to empirical treatment in prolonged febrile neutropenia? Medwave. 2016; 16 Suppl 2: e6463. https://doi.org/10.5867/medwave.2016.6463

Portugal RD, Garnica M, Nucci M. Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve. J Clin Oncol. 2009;27(23): 3849–54. https://doi.org/10.1200/JCO.2008.21.0856

Sprute R, Nacov JA, Neofytos D, et al. Antifungal prophylaxis and pre-emptive therapy: When and how? Mol Aspect Med. 2023;92:101190. https://doi.org/10.1590/1982-0194201900094

Çağlar İ, Devrim I, Özdemir H, et al. Antifungal consumption, indications and selection of antifungal drugs in paediatric tertiary hospitals in Turkey: Results from the first national point prevalence survey. J Glob Antimicrob Resist. 2018;15:232–8. https://doi.org/10.1016/j.jgar.2018.08.007

Leadebal ODCP, Pereira RR, Nóbrega LMB, et al. Prevalence of high risk of clinical complications associated with death from AIDS. Acta Paul Enferm. 2019;32(6):683–90. https://doi.org/10.1590/1982-0194201900094

Panis C, Matsuo T, Reiche EM. Nosocomial infections in human immunodeficiency virus type 1 (HIV-1) infected and AIDS patients: major microorganisms and immunological profile. Braz J Microbiol. 2009;40(1):155–62. https://doi.org/10.1590/S1517-838220090001000027

Oliveira AB, Dias OM, Mello MM, et al. Factors associated with increased mortality and prolonged length of stay in an adult intensive care unit. Rev Bras Ter Intensiva. 2010;22(3):250–6. https://doi.org/10.1590/S0103-507X2010000300006

Zilberberg MD, Kramer AA, Higgins TL, et al. Prolonged acute mechanical ventilation: implications for hospital benchmarking. Chest. 2009;135(5):1157–62. https://doi.org/10.1378/chest.08-1928

Guay J, Ochroch EA, Kopp S. Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in adults without acute lung injury. Cochrane Database Syst Rev. 2018;7(7):CD011151. https://doi.org/10.1002/14651858.CD011151.pub3

World Health Organization. Conceptual framework for the international classification for patient safety. 2009. https://www.who.int/patientsafety/taxonomy/icps_full_report.pdf. Accessed on February 2nd, 2024.

Fan L, Liu Q, Gui L. Efficacy of nonswallow nasogastric tube intubation: a randomised controlled trial. J Clin Nurs. 2016;25(21–22):3326–32. https://doi.org/10.1111/jocn.13398

Motta APG, Rigobello MCG, Silveira RCCP, et al. Nasogastric/ nasoenteric tube-related adverse events: an integrative review. Rev Lat Am Enfermagem. 2021;29:e3400. https://doi.org/10.1590/1518-8345.3355.3400

Brooks M. Pneumothorax events linked to placement of enteral feeding tube. New York: Medscape; 2018.

Thaden JT, Maskarinec SA. When two for the price of one isn't a bargain: estimating prevalence and microbiology of bacterial co-infections in patients with COVID-19. Clin Microbiol Infect. 2020;26(12):1602–3. https://doi.org/10.1016/j.cmi.2020.09.002

Muñoz P, Valerio M, Vena A, et al. Antifungal stewardship in daily practice and health economic implications. Mycoses. 2015; 58 Suppl 2:14–25. https://doi.org/10.1111/myc.12329

Pappas PG, Kauffman CA, Andes D, et al. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35. https://doi.org/10.1086/596757

Santolaya ME, Alvarez AM, Acuña M, et al. Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial. J Antimicrob Chemother. 2018; 73(10):2860–6. https://doi.org/10.1093/jac/dky244

Bailly S, Bouadma L, Azoulay E, et al. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients. Am J Respir Crit Care Med. 2015;191(10):1139–46. https://doi.org/10.1164/rccm.201409-1701OC

Bassetti M, Righi E, Ansaldi F, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med. 2014;40(6):839–45. https://doi.org/10.1007/s00134-014-3310-z

Berman J, Krysan DJ. Drug resistance and tolerance in fungi. Nat Rev Microbiol. 2020;18(6):319–31. https://doi.org/10.1038/s41579-019-0322-2

Canela HMS, Cardoso B, Vitali LH, et al. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil. Mycoses. 2018;61(1):11–21. https://doi.org/10.1111/myc.12695

Colombo AL, Garnica M, Aranha Camargo LF, et al. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol. 2013;51(1):38–44. https://doi.org/10.3109/13693786.2012.698024

Doi AM, Pignatari AC, Edmond MB, et al. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program. PLoS One. 2016;11(1):e0146909. https://doi.org/10.1371/journal.pone.0146909

Motta FA, Dalla-Costa LM, Muro MD, et al. Risk factors for candidemia mortality in hospitalized children. J Pediatr (Rio J). 2017;93(2):165–71. https://doi.org/10.1016/j.jped.2016.05.007

Medeiros MAP, Melo APV, Bento AO, et al. Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study. PLoS One. 2019;14(8):e0221033. https://doi.org/10.1371/journal.pone.0221033

Souza LKH, Costa CR, Fernandes OF, et al. Clinical and microbiological features of cryptococcal meningitis. Rev Soc Bras Med Trop. 2013;46(3):343–7. https://doi.org/10.1590/0037-8682-0061-2012

Mezzari A, Wliebbelling AMP, Freitas GSO, et al. Cryptococcosis in a public hospital in Porto Alegre: epidemiological data. 2013. https://lume.ufrgs.br/handle/10183/196745. Accessed on February 2nd, 2024.

Mora DJ, Colombo ERC, Ferreira-Paim K, et al. Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil. Mycopathology. 2012;173(5–6):321–7. https://doi.org/10.1007/s11046-011-9504-9

Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV. Organización Panamericana de la Salud 2020; https://iris.paho.org/handle/10665.2/52304. Accessed on February 2nd, 2024.

Sousa-Neto AL, Brito Röder DVD, Pedroso RS. Invasive fungal infections in people living with HIV/AIDS. J Biosc Med. 2020;08(09):15–26. https://doi.org/10.4236/jbm.2020.89002

Almeida MA, Almeida-Silva F, Guimarães AJ, et al. The occurrence of histoplasmosis in Brazil: A systematic review. Int J Infect Dis. 2019;86:147–56. https://doi.org/10.1016/j.ijid.2019.07.009

Downloads

Published

2024-03-08

How to Cite

Pedroso, R. dos S., Maria Pinto Monteiro Antonieti, F., Ângela Ribeiro, M. ., Borges de Araújo, L. ., & Von Dolinger de Brito Roder, D. . (2024). Clinical characteristics, epidemiology, and mortality of patients receiving antifungal therapy at a university hospital of the Triângulo Mineiro, Brazil. Revista De Epidemiologia E Controle De Infecção, 14(1). https://doi.org/10.17058/reci.v14i1.18687

Issue

Section

ORIGINAL ARTICLE